You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RAPP Sale Disclosure
Yeleswaram Krishnaswamy · SEC Form 4 · Filed Aug 26, 2026
Sale
Calculated transaction value
$1.05M
Yeleswaram Krishnaswamy Chief Development Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Aug 25, 2026
Public filing date
Aug 26, 2026
Filing lag
Filed 1 day later
RAPP daily price context
Close on/before transaction
$51.17
Aug 25, 2026
First close after public filing
$50.83
Aug 27, 2026
30-day return after filing
-33.29%
Through Sep 25, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,799 shares @ $50.31
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-368244
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.53M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP Current | Sale | Aug 25, 2026 | $1.05M |
| Rapport Therapeutics, Inc. RAPP | Sale | Aug 25, 2026 | $827.18K |
| Rapport Therapeutics, Inc. RAPP | Sale | Aug 24, 2026 | $657.98K |